DE602005023260D1 - Markierungsreagentien, markierte analyten, einschliesslich mischungen davon, und davon abgeleitete fragmentionen und verfahren zu deren analyse - Google Patents

Markierungsreagentien, markierte analyten, einschliesslich mischungen davon, und davon abgeleitete fragmentionen und verfahren zu deren analyse

Info

Publication number
DE602005023260D1
DE602005023260D1 DE602005023260T DE602005023260T DE602005023260D1 DE 602005023260 D1 DE602005023260 D1 DE 602005023260D1 DE 602005023260 T DE602005023260 T DE 602005023260T DE 602005023260 T DE602005023260 T DE 602005023260T DE 602005023260 D1 DE602005023260 D1 DE 602005023260D1
Authority
DE
Germany
Prior art keywords
methods
including mixtures
analysis
fragmentions
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005023260T
Other languages
English (en)
Inventor
Subhakar Dey
Darryl J C Pappin
Subhasish Purkayastha
Sasi Pillai
James M Coull
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/751,353 external-priority patent/US20050147982A1/en
Priority claimed from US10/751,387 external-priority patent/US7355045B2/en
Priority claimed from US10/822,639 external-priority patent/US20050147985A1/en
Priority claimed from US10/852,730 external-priority patent/US20050148087A1/en
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Publication of DE602005023260D1 publication Critical patent/DE602005023260D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602005023260T 2004-01-05 2005-01-05 Markierungsreagentien, markierte analyten, einschliesslich mischungen davon, und davon abgeleitete fragmentionen und verfahren zu deren analyse Active DE602005023260D1 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US10/751,388 US7307169B2 (en) 2004-01-05 2004-01-05 Isotopically enriched N-substituted piperazines and methods for the preparation thereof
US10/751,354 US20050148771A1 (en) 2004-01-05 2004-01-05 Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof
US10/751,353 US20050147982A1 (en) 2004-01-05 2004-01-05 Mixtures of isobarically labeled analytes and fragments ions derived therefrom
US10/751,387 US7355045B2 (en) 2004-01-05 2004-01-05 Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof
US10/822,639 US20050147985A1 (en) 2004-01-05 2004-04-12 Mixtures of isobarically labeled analytes and fragments ions derived therefrom
US10/852,730 US20050148087A1 (en) 2004-01-05 2004-05-24 Isobarically labeled analytes and fragment ions derived therefrom
PCT/US2005/000223 WO2005068446A1 (en) 2004-01-05 2005-01-05 Labeling reagents, labeled analytes, including mixtures thereof, and fragment ions derived therefrom and methods for the analysis thereof

Publications (1)

Publication Number Publication Date
DE602005023260D1 true DE602005023260D1 (de) 2010-10-14

Family

ID=34799954

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005023260T Active DE602005023260D1 (de) 2004-01-05 2005-01-05 Markierungsreagentien, markierte analyten, einschliesslich mischungen davon, und davon abgeleitete fragmentionen und verfahren zu deren analyse

Country Status (7)

Country Link
US (4) US20050148771A1 (de)
EP (2) EP1701945B1 (de)
AT (1) ATE479669T1 (de)
AU (1) AU2005205522A1 (de)
CA (1) CA2552304C (de)
DE (1) DE602005023260D1 (de)
WO (1) WO2005068446A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799576B2 (en) * 2003-01-30 2010-09-21 Dh Technologies Development Pte. Ltd. Isobaric labels for mass spectrometric analysis of peptides and method thereof
EP1916527A1 (de) * 2003-11-26 2008-04-30 Applera Corporation Analyse von Massenspektraldaten in ruhigen Bereichen
JP4838725B2 (ja) * 2003-11-26 2011-12-14 ディーエイチ テクノロジーズ デベロップメント プライベート リミテッド クワイエットゾーン中の質量スペクトルデータの分析
US20050148087A1 (en) 2004-01-05 2005-07-07 Applera Corporation Isobarically labeled analytes and fragment ions derived therefrom
US20050148771A1 (en) 2004-01-05 2005-07-07 Applera Corporation. Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof
WO2005085869A2 (en) 2004-03-01 2005-09-15 Applera Corporation Determination of analyte characteristics based upon binding properties
US20070054345A1 (en) * 2004-05-19 2007-03-08 Hunter Christie L Expression quantification using mass spectrometry
US20080206737A1 (en) * 2004-05-19 2008-08-28 Hunter Christie L Expression quantification using mass spectrometry
US20060078960A1 (en) * 2004-05-19 2006-04-13 Hunter Christie L Expression quantification using mass spectrometry
US20070048752A1 (en) * 2004-07-12 2007-03-01 Applera Corporation Mass tags for quantitative analyses
EP1776588A1 (de) * 2004-07-12 2007-04-25 Applera Corporation Massen-tags für quantitative analysen
US20060183238A1 (en) 2005-02-09 2006-08-17 Applera Corporation Amine-containing compound analysis methods
US20070037286A1 (en) * 2005-02-09 2007-02-15 Subhasish Purkayastha Thyroxine-containing compound analysis methods
US8975404B2 (en) * 2006-01-24 2015-03-10 Dh Technologies Development Pte. Ltd. Labeling reagents for analyte determination and methods and compounds used in making the same
CN101454488A (zh) 2006-05-26 2009-06-10 阿普里拉股份有限公司 用于羟基化化合物的标签试剂和方法
US7906341B2 (en) 2006-06-30 2011-03-15 Dh Technologies Development Pte, Ltd. Methods, mixtures, kits and compositions pertaining to analyte determination
US8362242B2 (en) 2006-06-30 2013-01-29 Dh Technologies Development Pte. Ltd. Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label
KR101081053B1 (ko) 2008-07-18 2011-11-07 포항공과대학교 산학협력단 가변질량 라벨링제와 이를 이용한 아미노산 서열 및 단백질정량 동시 분석방법
US20110003395A1 (en) 2009-05-31 2011-01-06 Dh Technologies Development Pte. Ltd. Specific analysis of analytes using reagent compounds, labeling strategies, and mass spectrometry workflow
US9678083B2 (en) * 2009-10-14 2017-06-13 Dana-Farber Cancer Institute, Inc. Protected amine labels and use in detecting analytes
JP2013514537A (ja) * 2009-12-15 2013-04-25 ディーエイチ テクノロジーズ デベロップメント プライベート リミテッド タグ付け試薬およびｌｃ−ｍｓワークフローを用いた、アミノ酸およびアミン含有化合物の分析
EP2610243A4 (de) 2010-08-23 2014-04-02 Postech Acad Ind Found Markierungsmittel und aminosäuresequenz damit sowie verfahren zur durchführung simultaner quantitativer analysen mehrerer proteine
KR101229704B1 (ko) 2010-08-23 2013-02-05 포항공과대학교 산학협력단 동중체로 표지된 단백질 및 펩티드를 큰 질량의 ｙ－타입 이온을 이용하여 정량분석하는 방법
US8492163B2 (en) 2011-01-31 2013-07-23 Dh Technologies Development Pte. Ltd. Methods, mixtures, kits and compositions pertaining to analyte determination
US20120329661A1 (en) * 2011-05-18 2012-12-27 Guo Zengkui Isotope Labeling-Assisted Quantification (iLAQ) of Biological Compounds
US9835629B2 (en) 2012-05-18 2017-12-05 Pierce Biotechnology, Inc. Methods and reagents for biomolecule labeling, enrichment and gentle elution
JP6272834B2 (ja) 2012-05-18 2018-01-31 ディーエイチ テクノロジーズ デベロップメント プライベート リミテッド サイト特異的誘導とｌｃ／ｍｓ／ｍｓワークフローとを使用した脳腱黄色腫症バイオマーカーのパネルの解析
GB201521903D0 (en) * 2015-12-11 2016-01-27 Electrophoretics Ltd Isorbaric mass labels
CN113514531B (zh) * 2021-04-27 2022-10-25 清华大学 一种化合物的碎片离子预测方法及应用

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1932995A1 (de) * 1969-06-28 1971-01-07 Bosch Gmbh Robert Steuereinrichtung zum Steuern eines ersten Druckmittelstromes in Abhaengigkeit eines zweiten Druckmittelstromes
US3860581A (en) 1972-12-27 1975-01-14 American Home Prod Preparation of 1,4-benzodiazepines
DE2851953A1 (de) * 1978-12-01 1980-06-19 Thomae Gmbh Dr K Neue spectinomycylamine, verfahren zu ihrer herstellung und diese enthaltenden arzneimittel
AU5940186A (en) 1985-07-05 1987-01-08 Institut Fur Pflanzenschutzforschung 2, 6 - dimethyl - morpholine quartenary compounds
US4761415A (en) 1986-08-28 1988-08-02 Smithkline Beckman Corporation Dopamine-β-hydroxylase inhibitors
JPH01125357A (ja) 1987-11-06 1989-05-17 Dainippon Pharmaceut Co Ltd トリペプチドの誘導体
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5252296A (en) * 1990-05-15 1993-10-12 Chiron Corporation Method and apparatus for biopolymer synthesis
EP1130399B1 (de) * 1992-05-29 2009-04-01 The Rockefeller University Verfahren zur Bestimmung der Folge von Peptiden unter Verwendung eines Massenspektrometers
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
AU7247896A (en) 1995-09-29 1997-04-17 Scripps Research Institute, The Protein signature analysis
US6027890A (en) 1996-01-23 2000-02-22 Rapigene, Inc. Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
US6312893B1 (en) 1996-01-23 2001-11-06 Qiagen Genomics, Inc. Methods and compositions for determining the sequence of nucleic acid molecules
US6613508B1 (en) * 1996-01-23 2003-09-02 Qiagen Genomics, Inc. Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
CZ217698A3 (cs) * 1996-04-08 1998-12-16 Glaxo Group Limited Způsob sledování průběhu reakce
US5780232A (en) * 1996-05-28 1998-07-14 Atom Sciences, Inc. DNA sequencing, mapping, and diagnostic processes using hybridization and stable isotope labels of DNA
US6329180B1 (en) * 1996-09-13 2001-12-11 Alex M. Garvin Genetic analysis using peptide tagged in-vitro synthesized proteins
ATE243761T1 (de) 1996-10-04 2003-07-15 Dako As Sonden zur detektion von mycobakterien
DE69836013T2 (de) 1997-01-15 2007-05-24 Xzillion Gmbh & Co. Kg Massenmarkierte hybridisierungssonden
EP1027454B1 (de) 1997-01-23 2003-08-13 Xzillion GmbH & CO.KG Charakterisierung von polypeptiden
ATE240408T1 (de) 1997-07-22 2003-05-15 Qiagen Genomics Inc Verfahren und verbindungen zur analysierung von nukleinsaeuren durch massenspektrometrie
JP4296608B2 (ja) * 1997-08-27 2009-07-15 田辺三菱製薬株式会社 Ｐｐａｒのアゴニスト及びアンタゴニストのスクリーニング方法
EP1017800B1 (de) 1997-09-23 2006-11-08 Sarissa, Inc. Antisense-oligonukleotide gegen thymidylatsynthase
GB9823646D0 (en) * 1997-12-19 1998-12-23 Brax Genomics Ltd Compounds for mass spectrometry
US6428956B1 (en) * 1998-03-02 2002-08-06 Isis Pharmaceuticals, Inc. Mass spectrometric methods for biomolecular screening
DE69912444T3 (de) 1998-08-25 2010-05-06 University Of Washington, Seattle Schnelle quantitative analyse von proteinen oder proteinfunktionen in komplexen gemischen
US6270976B1 (en) * 1998-09-15 2001-08-07 Brax Group Limited Characterizing nucleic acid by mass spectrometry
US6319476B1 (en) * 1999-03-02 2001-11-20 Perseptive Biosystems, Inc. Microfluidic connector
US6629040B1 (en) * 1999-03-19 2003-09-30 University Of Washington Isotope distribution encoded tags for protein identification
US6403309B1 (en) * 1999-03-19 2002-06-11 Valigen (Us), Inc. Methods for detection of nucleic acid polymorphisms using peptide-labeled oligonucleotides and antibody arrays
US6472156B1 (en) * 1999-08-30 2002-10-29 The University Of Utah Homogeneous multiplex hybridization analysis by color and Tm
GB0006141D0 (en) 2000-03-14 2000-05-03 Brax Group Ltd Mass labels
WO2001086296A2 (en) 2000-05-05 2001-11-15 Agilix Corporation Highly multiplexed reporter carrier systems
WO2002014867A2 (en) 2000-08-11 2002-02-21 Agilix Corporation Ultra-sensitive detection systems
US7045296B2 (en) * 2001-05-08 2006-05-16 Applera Corporation Process for analyzing protein samples
GB0115581D0 (en) 2001-06-26 2001-08-15 Glaxo Group Ltd Method of mass spectometry
DE60223696T2 (de) 2001-09-14 2009-01-29 Electrophoretics Ltd., Cobham Massenmarker
AU2002340490A1 (en) 2001-11-09 2003-05-19 Bayer Healthcare Ag Isotopically coded affinity markers 3
WO2003077851A2 (en) 2002-03-11 2003-09-25 Hk Pharmaceuticals, Inc. Compounds and methods for analyzing the proteome
US7473535B2 (en) 2002-08-20 2009-01-06 The Institute For Systems Biology Chemical reagents and methods for detection and quantification of proteins in complex mixtures
US7799576B2 (en) 2003-01-30 2010-09-21 Dh Technologies Development Pte. Ltd. Isobaric labels for mass spectrometric analysis of peptides and method thereof
GB0306756D0 (en) 2003-03-24 2003-04-30 Xzillion Gmbh & Co Kg Mass labels
US20050148771A1 (en) 2004-01-05 2005-07-07 Applera Corporation. Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof
US7355045B2 (en) * 2004-01-05 2008-04-08 Applera Corporation Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof

Also Published As

Publication number Publication date
US20050148773A1 (en) 2005-07-07
US7307169B2 (en) 2007-12-11
ATE479669T1 (de) 2010-09-15
EP1701945B1 (de) 2010-09-01
US20080114169A1 (en) 2008-05-15
EP1701945A1 (de) 2006-09-20
EP2251334A1 (de) 2010-11-17
US8569304B2 (en) 2013-10-29
US20090227791A1 (en) 2009-09-10
EP2251334B1 (de) 2013-08-14
US20050148771A1 (en) 2005-07-07
US7932388B2 (en) 2011-04-26
CA2552304A1 (en) 2005-07-28
WO2005068446A1 (en) 2005-07-28
AU2005205522A1 (en) 2005-07-28
CA2552304C (en) 2012-03-27

Similar Documents

Publication Publication Date Title
DE602005023260D1 (de) Markierungsreagentien, markierte analyten, einschliesslich mischungen davon, und davon abgeleitete fragmentionen und verfahren zu deren analyse
WO2008105896A3 (en) Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label
DK1721992T3 (da) Fremgangsmåder og nukleinsyrer til analyser af cellulære proliferative sygdomme
ATE515488T1 (de) Click-chemie zur herstellung von reportermolekülen
ATE483825T1 (de) Zusammensetzungen für die identifizierung von adenoviren
DK2253718T3 (da) Fast overflade til biomolekylafgivelse og analyse med høj omsætning
ATE490466T1 (de) Als interne funktionskontrolle in tests zum nachweis von seltenen zellen verwendete markierte zellen
DE60318642D1 (de) Multi-Test-Analyse von Echzeit-Nukleinsäureamplifikationen
DE602005025401D1 (de) Hes verfahren unter verwendung davon
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
DE60230672D1 (de) Nukleinsäureanreicherung
ATE515702T1 (de) Verfahren, mixturen, kits und zusammensetzungen bezüglich der analytbestimmung
WO2009086509A3 (en) Reagents for biomolecular labeling, detection and quantification employing raman spectroscopy
DE602004021185D1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
DE602007000887D1 (de) Reagens, Ausstattung und Verfahren zur Probenanalyse
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
ATE480642T1 (de) Verfahren zur bestimmung von genotoxizität
ATE525649T1 (de) Nachweis von proteinen mit veränderter konformation
DE602005008146D1 (de) Methode für die Quantifizierung der Ausgangs-Konzentration von Nukleinsäuren ausgehend von real-time Amplifikationsdaten
ATE553216T1 (de) Sonden, bibliotheken und kits zur analyse von nukleinsäuregemischen und verfahren zu deren konstruktion
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
DE60236262D1 (de) Elektrophorese mit doppelstrang-dna-marker
GB2437545B (en) Dextrin-containing reagents for detecting and quantifying proteins
ATE504833T1 (de) Verfahren zur bestimmung des phänotyps von zellen
ATE510029T1 (de) Verfahren zur analyse von nukleinsäuren